Bulletin
Investor Alert

June 12, 2020, 9:16 a.m. EDT

Stocks Trading Above 50 Days Moving Average: $ONTX $OBSV $REED

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Onconova Therapeutics Inc. (ONTX)
  • X
    ObsEva S.A. (OBSV)
  • X
    Reed's Inc. (REED)

or Cancel Already have a watchlist? Log In

Jun 12, 2020 (The Market Signal via Comtex) -- The Market Signal was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/202644326/composite ONTX -15.57% , /zigman2/quotes/208216166/composite OBSV -5.96% or /zigman2/quotes/204915696/composite REED -5.76% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

https://themarketsignal.com/free-report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Onconova gave overview of company's lead candidate in virtual BIO Digital 2020 event

https://themarketsignal.com/free-report/ONTX

(Click link above or copy, paste and hit enter in your browser for your report)

The Phase 3 stage biopharmaceutical company, Onconova Therapeutics Inc /zigman2/quotes/202644326/composite ONTX -15.57% is focused mainly on development and discovery of cancer treatments and is currently trading 67.20% above its 50 Days simple moving average. This stock looks bullish at present. The company has its initial focus on myelodysplastic syndromes (MDS).

It recently presented at the virtual BIO Digital 2020, which concluded today, i.e., on June 12, 2020. The event took place from June 8 until today and company's Senior Vice President of the Corporate Development, Avi Oler participated in the event. While the Vice-President explained about the upcoming milestones and corporate development objectives in the vents, another crucial presentation was on rigosertib, the lead candidate, as well as another oncology candidate in the pipeline.

Obseva presents case report from pilot study of linzagolix use in uterine adenomyosis treatment

https://themarketsignal.com/free-report/OBSV

(Click link above or copy, paste and hit enter in your browser for your report)

The biopharmaceutical company, Obseva SA /zigman2/quotes/208216166/composite OBSV -5.96% is known for development and commercialization of therapies meant for improvement of reproductive health of females. His month, the company had presented a case report from the pilot study, which assesses linzagolix use in uterine adenomyosis treatment. The stock is currently trading 54.44% above its 50 Days simple moving average and the stock looks bullish.

The company's publication is presented in the journal called Fertility and Sterility of "Gonadotropin-releasing Hormone Antagonist (linzagolix): a New Therapy for Uterine Adenomyosis".

Adenomyosis is a condition related to females that is driven mainly due to estrogen, the female reproductive hormone. In this condition, the inner line of uterus, called endometrial tissue is present inside muscular uterine wall or myometrium, which caused enlarged uterus and leads to dysmenorrhea (painful menstruation), heavy bleeding and infertility.

A look at the Reed 's liquidity position in Q1-2020

https://themarketsignal.com/free-report/REED

(Click link above or copy, paste and hit enter in your browser for your report)

Reed's, Inc. /zigman2/quotes/204915696/composite REED -5.76% is currently trading 51.01% above its 50 Days simple moving average and the stock looks bullish. Looking at the quarterly liquidity position of this company at present, it is observed that the cash used in the company's operating activities is $2.4 million in Q1-2020, as against $8.8 million in the corresponding period in previous year.

There has been a reported decrease in cash for operating activities, which primarily attributes to declining inventory of finished goods, along with lesser net loss. The company ended its first quarter with $3.0 million borrowing capacity in revolving credit line, as of March 31, 2020.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

The post Stocks Trading Above 50 Days Moving Average: $ONTX $OBSV $REED appeared first on The Market Signals .

COMTEX_366842562/2662/2020-06-12T09:16:28

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/202644326/composite
US : U.S.: Nasdaq
$ 0.27
-0.05 -15.57%
Volume: 20.69M
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$57.47 million
Rev. per Employee
$52,480
loading...
/zigman2/quotes/208216166/composite
US : U.S.: Nasdaq
$ 2.61
-0.17 -5.96%
Volume: 548,201
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$154.89 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204915696/composite
US : U.S.: Nasdaq
$ 0.93
-0.06 -5.76%
Volume: 180,051
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$61.91 million
Rev. per Employee
$733,481
loading...
/zigman2/quotes/202644326/composite
US : U.S.: Nasdaq
$ 0.27
-0.05 -15.57%
Volume: 20.69M
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$57.47 million
Rev. per Employee
$52,480
loading...
/zigman2/quotes/208216166/composite
US : U.S.: Nasdaq
$ 2.61
-0.17 -5.96%
Volume: 548,201
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$154.89 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204915696/composite
US : U.S.: Nasdaq
$ 0.93
-0.06 -5.76%
Volume: 180,051
Sept. 23, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$61.91 million
Rev. per Employee
$733,481
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.